Journal of International Oncology››2015,Vol. 42››Issue (1): 22-26.doi:10.3760/cma.j.issn.1673-422X.2015.01.006
Previous ArticlesNext Articles
Cui Yunfu, Hao Tao, Wang Ronghua, Li Baosong, Ma Chong, Fan Peng
Received:
2014-08-18Revised:
2014-10-08Online:
2015-01-08Published:
2015-01-07Contact:
Hao Tao E-mail:anmly521@163.comCui Yunfu, Hao Tao, Wang Ronghua, Li Baosong, Ma Chong, Fan Peng. Construction and inhibitory effect of microRNA expression vector targeting survivin on proliferation of human colorectal carcinoma HT-29 cells[J]. Journal of International Oncology, 2015, 42(1): 22-26.
[1] Okoniewski MJ, Hey Y, Pepper SD, et al. High correspondence between Affymetrix exon and standard expression arrays[J]. Biotechniques, 2007, 42(2): 181-185. [2] Sarela AI, Macadam RC, Farmery SM, et al. Expression of the antiapoptosis gene, survivin, predicts death from recurrent colorectal carcinoma[J]. Gut, 2000, 46(5): 645-650. [3] Lu B, Mu Y, Cao C, et al. Survivin as a therapeutic target for radiation sensitization in lung cancer[J]. Cancer Res, 2004, 64(8):2840-2845. [4] Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin4 encodes small RNAs with antisense complementarity to lin14[J]. Cell, 1993, 75(5): 843-854. [5] Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay[J]. Nat Rev Genet, 2010, 11(9): 597-610. [6] Rachagani S, Kumar S, Batra SK. MicroRNA in pancreatic cancer: pathological, diagnostic and therapeutic implications[J]. Cancer Lett, 2010, 292(1): 8-16. [7] AlvarezGarcia I, Miska EA. MicroRNA functions in animal development and human disease[J]. Development, 2005, 132(2): 4653-4662. [8] 张冬雪, 陈璐璐, 廖云飞. 微小RNA在2型糖尿病相关机制中的研究进展[J]. 中华内分泌代谢杂志, 2012, 28(11): 944-947. [9] 孙婷婷, 罗善顺, 韩辉. 微小RNA与动脉粥样硬化的研究进展[J]. 中华老年心血管病杂志, 2013, 15(2): 211-212. [10] Banaudha KK, Verma M. The role of microRNAs in the management of liver cancer[J]. Methods Mol Biol, 2012, 863: 241-251. [11] Hong L, Han Y, Zhang H, et al. The prognostic and chemotherapeutic value of miR296 in esophageal squamous cell carcinoma[J]. Ann Surg, 2010, 251(6): 1056-1063. [12] Yu Z, Willmarth NE, Zhou J, et al. microRNA 17/20 inhibits cellular invasion and tumor metastasis in breast cancer by heterotypic signaling[J]. Proc Natl Acad Sci USA, 2010, 107(18): 8231-8236. [13] Cunmins JM, He Y, Leary RJ, et al. The colorectal microRNAome[J]. Proc Natl Acad Sci USA, 2006, 103(10): 3687-3692. [14] Zeng Y. Principles of microRNA production and maturation[J]. Oncogene, 2006, 25(46): 6156-6162. [15] Wang J, Jin Y, Xu Z, et al. Involvement of caspase3 activity and survivin downregulation in cinobufociniinduced apoptosis in A549 cells[J]. Exp Biol Med (Maywood), 2009, 234(5): 566-572. [16] Delvaeye M, De Vriese A, Zwerts F, et al. Role of the 2 zebrafish survivin genes in vasculoangiogenesis, neurogenesis, cardiogenesis and hematopoiesis[J]. BMC Dev Biol, 2009, 9: 25. [17] Mesri M, MoralesRuiz M, Ackermann EJ, et al. Suppression of vascular endothelial growth factormediated endothelial cell protection by survivin targeting [J]. Am J Pathol, 2001, 158(5): 1757-1765. |
[1] | Ren Lu, Xie Xiaoli, Zhang Kun, Wang Lijuan.Effects and mechanisms of dihydroartemisinin combined with carfilzomib on the activity, proliferation, and apoptosis of multiple myeloma cells[J]. Journal of International Oncology, 2024, 51(3): 129-136. |
[2] | Gong Yan, Chen Honglei.Research progress on the mechanism of microRNA regulation of cisplatin resistance in ovarian cancer[J]. Journal of International Oncology, 2024, 51(3): 186-190. |
[3] | Xiang Yuling, Tan Jiajie, Xiong Yuanguo, Zhao Lirong, Li Chen, Zhang Hong.Effects of Anhydroicaritin on the proliferation, migration and apoptosis of hepatocellular carcinoma cells[J]. Journal of International Oncology, 2023, 50(9): 513-519. |
[4] | Quan Zhenhao, Xu Feipeng, Huang Zhe, Huang Xianjin, Chen Rihong, Sun Kaiyu, Hu Xu, Lin Lin.lncRNA FTX silencing inhibits gastric cancer cell proliferation through the miR-22-3p/NLRP3 inflammasome pathway[J]. Journal of International Oncology, 2023, 50(4): 202-207. |
[5] | Chu Xuelei, Mao Yun, Xue Peng, Li Linlu, Chen Meichi, Yuan Chunsheng, Qin Xiaoyan, Zhu Shijie.Effects of chemotherapy dose intensity on short-term efficacy in patients with advanced colon cancer: a study based on real-world data[J]. Journal of International Oncology, 2022, 49(7): 408-415. |
[6] | Lian Haiwei, Yang Shuorui, Liu Renzhong.Mechanism study on regulation of glioblastoma cell proliferation and apoptosis by sciadopitysin combined with CX-4945 through Notch1 pathway[J]. Journal of International Oncology, 2022, 49(6): 321-326. |
[7] | Zhou Renbang, Zhang Zhongchuan, Xu Zhiyuan, Zhu Xunbing.MiR-219a-5p inhibits the proliferation, invasion and migration of osteosarcoma U2OS cells by negatively regulating HMGA2[J]. Journal of International Oncology, 2022, 49(4): 193-198. |
[8] | Laibijiang Wusiman, Cao Bowei, Zhang Wenbin, Gao Hua.Effects of exogenous AGR2 on the proliferation and invasion abilities of colon cancer cells[J]. Journal of International Oncology, 2022, 49(2): 73-78. |
[9] | Jin Jiahui, Chen Cunhai, Ma Xuezhen.Effects of radiation-associated miRNA in radiotherapy for breast cancer[J]. Journal of International Oncology, 2022, 49(12): 735-738. |
[10] | Jing Wenjun, Zhao Wenwen, Feng Qingqing, Zhao Wenfei, Zhao Lili, Zhang Xue, Wei Hongmei.Molecular basis and clinical prospect of the miR-34 family for the treatment of gastric cancer[J]. Journal of International Oncology, 2022, 49(11): 681-686. |
[11] | Luo Liyun, Lai Canhui, Liang Renpei, Yang Aiwu, Lin Zhimin.Correlation between the expressions of miR-524-5p and SOX9 in advanced gastric cancer and their influences on chemotherapy efficacy and prognosis[J]. Journal of International Oncology, 2022, 49(1): 45-50. |
[12] | Hong Anlan, Cao Meng, Wang Yan, Fang Fang.Research progress on lncRNAs as members of ceRNA network in melanoma[J]. Journal of International Oncology, 2022, 49(1): 61-64. |
[13] | Zhang Yongli, Zhang Ruojia, Fan Huancai, Ge Luna, Wang Lin.TXNDC5-Prx2 axis regulates drug resistance of prostate cancer cells[J]. Journal of International Oncology, 2021, 48(8): 473-478. |
[14] | Liu Pei, Pu Jiaze, Huang Wen, Wang Fei.Expression differences of miR-200c, miR-19a and miR-155 in gefitinib sensitive and drug resistant NSCLC patients and their effects on prognosis[J]. Journal of International Oncology, 2021, 48(7): 409-414. |
[15] | Wang Yang, Liu Qian, Long Hui, Wu Qingming.Research status of fecal detection for colorectal cancer markers[J]. Journal of International Oncology, 2021, 48(7): 441-444. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||